Screener
Apyx Medical Corporation APYX Shares (Diluted)
Discontinued — last reported Q4 '23
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Apyx Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Apyx Medical Corporation’s 10-K, filed March 21, 2024.
- Filed
- Mar 21, 2024
- Fiscal year
- FY2023
- Accession
- 0000719135-24-000016
| Line item | Year Ended December 31, 2023 | Year Ended December 31, 2022 |
|---|---|---|
| Total other (loss) income, net | (4,023) | 651 |
| Loss from operations before income taxes | (21,282) | (22,911) |
| Income tax (benefit) expense | (2,432) | 367 |
| Net loss | (18,850) | (23,278) |
| Net loss attributable to non-controlling interest | (137) | (94) |
| Net loss attributable to stockholders | $(18,713) | $(23,184) |
| Loss per share - basic and diluted | $(0.54) | $(0.67) |
| Weighted average number of shares outstanding - basic and diluted | 34,622 | 34,516 |
ITEM 8. Financial Statements and Supplementary Data
FAQ
- What is Apyx Medical Corporation's shares (diluted)?
- Apyx Medical Corporation (APYX) reported shares (diluted) of 34.6M in Q4 2023.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Apyx Medical Corporation's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude